Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial - The Lancet - 2003
Brief Summary:
In patients with HFrEF (EF ≤35%) and NYHA II-IV symptoms, Carvedilol reduced all-cause mortality compared to metoprolol tartrate.Reference: http://www.ncbi.nlm.nih.gov/pubmed/12853193
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you